Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Single cell genomic technologies in brain tumours

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.05.18
Views: 225

Dr Mario Suvà - Massachusetts General Hospital, Boston, USA

Dr Suvà speaks with ecancer at the Cancer Research UK Brain Tumour Conference 2018 in London about nucleic information derived from individual cancer cells.

He describes how cancer cells are stratified by cell type and activity, and how new technologies to increase specificity in cellular profiling reduces the inclusion of healthy patient tissue, and opens treatment options in immunotherapies and targeted therapies.
 

Related videos

follow us

NCRI 2018


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation